Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
Open Access
- 15 June 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 13 (5) , 758-767
Abstract
Glomerulonephritis (GN) is the underlying cause of end-stage renal failure in 30–50% of kidney transplant recipients. It represents the primary cause of end-stage renal disease for 25% of the dialysis population and 45% of the transplant population. For patients with GN requiring renal replacement therapy, kidney transplantation is associated with superior outcomes compared with dialysis. Recurrent GN was previously considered to be a minor contributor to graft loss, but with the prolongation of graft survival, the effect of recurrent disease on graft outcome assumes increasing importance. Thus the extent of recurrence of original kidney disease after kidney transplantation has been underestimated for several reasons. This review aims to provide updated knowledge on one particular recurrent renal disease after kidney transplantation, immunoglobulin A nephropathy (IgAN). IgAN is one of the most common GNs worldwide. The pathogenesis of IgAN is complex and remains incompletely understood. Evidence to date is most supportive of a several hit hypothesis. Biopsy is mandatory not only to diagnose the disease in the native kidney, but also to identify and characterize graft recurrence of IgAN in the kidney graft. The optimal therapy for IgAN recurrence in the renal graft is unknown. Supportive therapy aiming to reduce proteinuria and control hypertension is the mainstream, with corticosteroids and immunosuppressive treatment tailored for certain subgroups of patients experiencing a rapidly progressive course of the disease with active lesions on renal biopsy and considering safety issues related to infectious complications.Keywords
This publication has 101 references indexed in Scilit:
- An update on the pathogenesis and treatment of IgA nephropathyKidney International, 2012
- Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathyJournal of Clinical Investigation, 2011
- Steroids and Recurrent IgA Nephropathy After Kidney TransplantationAmerican Journal of Transplantation, 2011
- Genome-wide association study identifies susceptibility loci for IgA nephropathyNature Genetics, 2011
- HLA Has Strongest Association with IgA Nephropathy in Genome-Wide AnalysisJournal of the American Society of Nephrology, 2010
- Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA NephropathyJournal of the American Society of Nephrology, 2008
- Complement 3 is involved in changing the phenotype of human glomerular mesangial cellsJournal of Cellular Physiology, 2007
- Recurrence of IgA Nephropathy Among Renal Allograft Recipients From Living Donors is Greater Among Those With Zero HLA MismatchesTransplantation, 2006
- Renal allograft glomerulopathy and the value of immunohistochemistryClinical Nephrology, 2004
- Recurrence of glomerulonephritis following renal transplantationNephrology Dialysis Transplantation, 1999